Advanced Biomedical Technologies Inc. (ABMT) SEC Filing 10-Q Quarterly report for the period ending Monday, July 31, 2017

Advanced Biomedical Technologies Inc.

CIK: 1385799 Ticker: ABMT
Document and Entity Information - shares
9 Months Ended
Jul. 31, 2017
Sep. 19, 2017
Entity Registrant NameAdvanced Biomedical Technologies Inc. 
Entity Central Index Key0001385799 
Document Type10-Q 
Document Period End DateJul. 31, 2017 
Amendment Flagfalse 
Current Fiscal Year End Date--10-31 
Entity a Well-known Seasoned IssuerNo 
Entity a Voluntary FilerNo 
Entity's Reporting Status CurrentYes 
Entity Filer CategorySmaller Reporting Company 
Entity Common Stock, Shares Outstanding 69,374,850
Document Fiscal Period FocusQ3 
Document Fiscal Year Focus2017 

View differences made from one quarter to another to evaluate Advanced Biomedical Technologies Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advanced Biomedical Technologies Inc..


Assess how Advanced Biomedical Technologies Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advanced Biomedical Technologies Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: ABMT
CIK: 1385799
Form Type: 10-Q Quarterly Report
Accession Number: 0001387131-17-004713
Submitted to the SEC: Tue Sep 19 2017 1:03:26 PM EST
Accepted by the SEC: Tue Sep 19 2017
Period: Monday, July 31, 2017
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: